11. Rodríguez, J.L.; García, J.L.; Giral, C.; Hernández, D.; Jasso, L. (2004). Farmacovigilancia II. Las reacciones adversas y el Programa Internacional de Monitoreo de los Medicamentos. IMSS-UAEM, 42(5) 419-423.
12. Sookoian, S., & Pirola, C.J. (2004). Farmacogenética/farmacogenómica en la práctica clínica. Medicina Buenos Aires, 64(6) 563-567. ISSN 1669-9106.
13. Chow FS, Sharma A, Jusko WJ Modeling interactions between adrenal suppression and T-helper lymphocyte trafficking during multiple dosing of methylprednisolone. [Journal Article, Research Support, U.S. Gov't, P.H.S.]J Pharmacokinet Biopharm 1999 Dec; 27(6):559-75
14. CallréusT,Odeberg J,Lundin S,et al. Indirect-response modeling of desmopressin at different levels of hydration. [ClinicalTrial, Journal Article Randomized Controlled Trial] J Pharmacokinet Biopharm 1999 Oct; 27(5):513-29.
15. Bauer RJ, Dedrick RL, White ML, et al. Population pharmacokinetics and pharmacodynamics of the anti-CD11a antibody hu1124 in human subjects with psoriasis. [Clinical Trial, Clinical Trial, Phase I, Journal Article] J Pharmacokinet Biopharm 1999 Aug; 27(4):397-420.
16. Korman B, Jennings LS. Rapid attainment of steady-state plasma drug concentrations within precise limits in multicompartment mammillary systems. [Journal Article, Research Support, Non-U.S. Gov't]. J Pharmacokinet Biopharm 1999 Jun; 27(3):325-8.
17. Singer J, Vereczkey L. Predicting the time needed to achieve steady state if absorption and elimination constants are equal. [Journal Article]. J Pharmacokinet Biopharm 1999 Jun; 27(3):297-300.
18. Weiss M. Cellular pharmacokinetics: effects of cytoplasmic diffusion and binding on organ transit time distribution. [Journal Article]. J Pharmacokinet Biopharm 1999 Jun; 27(3):233-56.
19. Meibohm B, Hochhaus G, Möllmann H, et al. A pharmacokinetic/pharmacodynamic approach to predict the cumulative cortisol suppression of inhaled corticosteroids. [Journal Article, Research Support, Non-U.S. Gov't]. J Pharmacokinet Biopharm 1999 Apr; 27(2):127-47.
20. Lalonde RL, Ouellet D, Kimanani EK, et al. Comparison of different methods to evaluate population dose-response and relative potency: importance of interoccasion variability. [Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial]. J Pharmacokinet Biopharm 1999 Feb; 27(1):67-83.